e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
36.89
+0.07 (+0.19%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
16,143,271
Open
36.85
Bid (Size)
37.05 (1,200)
Ask (Size)
37.08 (500)
Prev. Close
36.82
Today's Range
36.55 - 37.20
52wk Range
35.85 - 81.44
Shares Outstanding
N/A
Dividend Yield
3.17%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Think Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer
↗
March 24, 2026
The company recently obtained approval for a higher-dose version of Wegovy.
Via
The Motley Fool
Institutional Titans Bet Big on Amgen as Dividend Yield Hits 2.9% Benchmark
March 23, 2026
In a decisive show of confidence for the biotechnology sector, institutional heavyweights have significantly ramped up their positions in Amgen (NASDAQ: AMGN) throughout the first quarter of 2026....
Via
MarketMinute
Topics
ETFs
Earnings
Performance
YTD
-29.6%
-29.6%
1 Month
-6.9%
-6.9%
3 Month
-28.5%
-28.5%
6 Month
-38.0%
-38.0%
1 Year
-51.0%
-51.0%
More News
Read More
Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics?
↗
March 22, 2026
Via
The Motley Fool
Topics
Intellectual Property
Should You Buy Eli Lilly Stock Before April 10?
↗
March 22, 2026
Via
The Motley Fool
Is This Stock a Buy on the Dip?
↗
March 21, 2026
Via
The Motley Fool
This Hims & Hers Move Could Destroy Competitors
↗
March 21, 2026
Via
The Motley Fool
Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?
↗
March 20, 2026
Via
The Motley Fool
Is It Too Late to Buy Eli Lilly?
↗
March 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
1 Reason I'm Never Selling Novo Nordisk Stock
↗
March 19, 2026
Via
The Motley Fool
Hims & Hers (HIMS) 2026 Deep Dive: The $1.15B Eucalyptus Deal and the Branded Pivot
March 18, 2026
Via
Finterra
Topics
Intellectual Property
Hims & Hers Opens Up Pre-Launch Waitlist For Ozempic And Wegovy Following Partnership With Novo Nordisk
↗
March 18, 2026
Via
Stocktwits
The Best Healthcare Stocks to Buy With $50 Right Now
↗
March 18, 2026
Via
The Motley Fool
Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics
↗
March 17, 2026
Via
The Motley Fool
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move
↗
March 17, 2026
Via
The Motley Fool
Topics
Stocks
LLY Shares Dive On Analyst Downgrade Citing Obesity Market Overestimation Concerns, But Retail Dismisses ‘Absurd’ Selloff
↗
March 17, 2026
Via
Stocktwits
Why Eli Lilly Stock Just Dropped
↗
March 17, 2026
Via
The Motley Fool
This Promising GLP-1 Drug Could Give Novo Nordisk Investors Renewed Hope for the Stock
↗
March 17, 2026
Via
The Motley Fool
Should You Avoid Pfizer? Here's the Key Risk to Watch
↗
March 17, 2026
Via
The Motley Fool
Topics
Intellectual Property
Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks
↗
March 16, 2026
Via
The Motley Fool
Eli Lilly’s Employer Push Could Unlock New GLP-1 Demand
↗
March 15, 2026
Via
MarketBeat
MarketBeat Week in Review – 03/09 - 03/13
↗
March 14, 2026
Via
MarketBeat
Is Eli Lilly's Weight Loss Empire in Trouble?
↗
March 13, 2026
Via
The Motley Fool
3 Dirt-Cheap Stocks to Buy With $1,000 Right Now
↗
March 13, 2026
Via
The Motley Fool
Topics
Earnings
The Real Reason Eli Lilly Is Pouring $3 Billion Into China
↗
March 13, 2026
Via
MarketBeat
The Great Pivot: How the Novo Nordisk Deal Transformed Hims & Hers (HIMS) into a Healthcare Powerhouse
March 13, 2026
Via
Finterra
Topics
Economy
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 36.89
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 03/24/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.